Cardiology Group pays $2 million to settle bogus claims

Published Date: 02 Mar 2023

Florida Cardiology PA and 10 cardiologists have filed a bogus lawsuit and must pay $2 million to settle the lawsuit outside the United States and will still “deny” wrongdoing.

Read Full News

Latest News

FDA Approves New Narcan Packaging, Aiming to Boost Carry Rates

FDA Approves New Narcan Packaging, Aiming to Boost Carry Rates

FDA Approves Tradipitant (NEREUS) for the Prevention of Vomiting Induced by Motion

FDA Approves Tradipitant (NEREUS) for the Prevention of Vomiting Induced by Motion

Increases in Physician Attrition Rates Could Worsen Shortages

Increases in Physician Attrition Rates Could Worsen Shortages

Improving CRC Screening Rates With High-Quality, Noninvasive Tests, with Keith Winfrey, MD, MPH Keith Winfrey, MD, MPH

Winfrey discussed how noninvasive CRC screening tests can help meet gaps when patients face barriers to colonoscopy.

ACP Urges Concern for Health Policy Issues, with Shari Erickson, MPH Shari Erickson, MPH

Erickson discussed key health policy issues the ACP is pushing back against during the organization’s Internal Medicine meeting.

Reviving exhausted immune cells boosts tumor elimination

A new study has discovered a molecular signal that tumors exploit to exhaust the T cells meant to destroy them—and how silencing that signal could revive the body's immunity.

Todays Updates

Lilly's Zepbound and Taltz Improve Psoriasis Symptoms, Drive Weight Loss in Study

Eli Lilly said on Wednesday its weight-loss drug, Zepbound, used with psoriasis treatment Taltz, showed ⁠better results in patients with the skin disease and obesity in a...

Bimekizumab Eases Plaque Psoriasis Symptoms Up to 3 Years

Patients with moderate‑to‑severe plaque psoriasis achieve greater relief from itching, skin pain, and scaling with bimekizumab vs secukinumab up to 3 years.

Amivantamab Tied to Diverse Dermatologic Events in NSCLC

Treatment with amivantamab is associated with a broad spectrum of dermatologic adverse events that can be severe in patients with non-small cell lung cancer, a real-world study shows.

Measles Cases in South Carolina Rise by 12 to 962, State Health Department Says

South Carolina reported a surge to 962 measles cases on Tuesday, state health data showed, including ⁠12 additional infections since Friday, as officials warned the widening...

Urgent TRUE METRIX Glucose Meter Alert Updates Error Message

As currently written, the instructions could potentially lead to delayed treatment of high glucose levels.

Rural vs Urban: The Neonatal Care Divide in US Hospitals

An expansion of higher-level neonatal care has been observed in urban hospitals in the US over the years, whereas rural hospitals have faced a decline in such care capacity, per a recent study.

Todays Updates

Lilly's Zepbound and Taltz Improve Psoriasis Symptoms, Drive Weight Loss in Study

Eli Lilly said on Wednesday its weight-loss drug, Zepbound, used with psoriasis treatment Taltz, showed ⁠better results in patients with the skin disease and obesity in a...

Bimekizumab Eases Plaque Psoriasis Symptoms Up to 3 Years

Patients with moderate‑to‑severe plaque psoriasis achieve greater relief from itching, skin pain, and scaling with bimekizumab vs secukinumab up to 3 years.

Amivantamab Tied to Diverse Dermatologic Events in NSCLC

Treatment with amivantamab is associated with a broad spectrum of dermatologic adverse events that can be severe in patients with non-small cell lung cancer, a real-world study shows.

Measles Cases in South Carolina Rise by 12 to 962, State Health Department Says

South Carolina reported a surge to 962 measles cases on Tuesday, state health data showed, including ⁠12 additional infections since Friday, as officials warned the widening...

Urgent TRUE METRIX Glucose Meter Alert Updates Error Message

As currently written, the instructions could potentially lead to delayed treatment of high glucose levels.

Rural vs Urban: The Neonatal Care Divide in US Hospitals

An expansion of higher-level neonatal care has been observed in urban hospitals in the US over the years, whereas rural hospitals have faced a decline in such care capacity, per a recent study.

Latest News

FDA Approves New Narcan Packaging, Aiming to Boost Carry Rates

FDA Approves Tradipitant (NEREUS) for the Prevention of Vomiting Induced by Motion

Increases in Physician Attrition Rates Could Worsen Shortages

Winfrey discussed how noninvasive CRC screening tests can help meet gaps when patients face barriers to colonoscopy.

Erickson discussed key health policy issues the ACP is pushing back against during the organization’s Internal Medicine meeting.

A new study has discovered a molecular signal that tumors exploit to exhaust the T cells meant to destroy them—and how silencing that signal could revive the body's immunity.

News All Time

Gut bacterium may sabotage liver cancer immunotherapy, study suggests

A research team led by the Department of Clinical Oncology, Center of Cancer Medicine, School of Clinical Medicine, LKS Faculty of Medicine, the University of Hong Kong (HKUMed), has identified a critical factor contributing ...

Cellular protein FGD3 boosts breast cancer chemotherapy and immunotherapy, study finds

A naturally-occurring protein that tends to be expressed at higher levels in breast cancer cells boosts the effectiveness of some anticancer agents, including doxorubicin, one of the most widely used chemotherapies, and a ...

Global reviews call for urgent action on endometriosis in most world regions

Two reviews published in The Lancet Obstetrics, Gynecology & Women's Health reveal stark global inequities in how endometriosis is recognized, treated, and prioritized in national health systems.

Mental and physical coaching before surgery prepares immune system and reduces complications, trial finds

The weeks leading up to a major surgery can be a time of uncertainty and worry for patients, many of whom anticipate the need for rehabilitation to get back on their feet. But if patients improve their physical and mental ...

Flu vaccine performance varies by age, study reveals

New research comparing four different flu vaccines found that the ability of the vaccines to activate cells of the immune system that help to protect against infection varied greatly depending on the vaccine type and age ...

Study reveals why some myeloma patients stay cancer-free for years after CAR T therapy

A new study from the Icahn School of Medicine at Mount Sinai helps explain why some people with multiple myeloma, a type of blood cancer, stay in remission for many years after receiving CAR T cell therapy, while others see ...

Researchers aim to disrupt breast cancer line of communication and prevent spread

Cancer Center at Illinois (CCIL) Program Leader Erik Nelson's lab made an important discovery about the relationship between cholesterol and breast cancer progression with crucial implications for breast cancer therapeutics.

Study tracking how tumor microenvironment develops signals opportunity for early detection, risk prediction

Colorectal cancer precursor lesions are benign growths that can develop into colorectal cancer (CRC) over time, through either a conventional or serrated pathway. Understanding how the immune system reacts to these precursor ...

Rapid growth of radiopharmaceutical therapy highlights need for expertise

The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has released a position paper outlining the education, training, and experience needed to ensure the safe and effective delivery of radiopharmaceutical therapy ...

Blood test offers hope for more effective ovarian cancer treatment

New clinical research has identified a blood test that can reveal which women are more likely to respond to a particular treatment for ovarian cancer, known as PARP inhibitor therapy.

T cell therapies show long-term HPV gains

Researchers from Rutgers Cancer Institute, New Jersey's only National Cancer Institute (NCI)—designated Comprehensive Cancer Center, and RWJBarnabas Health, along with colleagues from the National Cancer Institute, a center ...

FDA grants fast track designation to drug combo for colorectal cancer

The U.S. Food and Drug Administration has granted Fast Track Designation to a new drug combination for metastatic colorectal cancer, following encouraging results from a clinical trial led in part by the University of Oklahoma ...

Q&A: Connection between a distinct immune cell and colitis discovered

CU Anschutz researchers uncovered a link between a type of mucosal immune cell and gut inflammation, finding that the cells exacerbate inflammation and lead to chronic disease in certain conditions.

Newly identified lymphoma subtype gives hope in fight against aggressive form of blood cancer

Researchers at the University of Southampton have identified a new subtype of lymphoma that could pave the way to improved and more targeted treatments for some blood cancer patients. The cancer scientists and biologists ...

Sleep issues linked to higher risk of severe asthma in children

About 30 to 40% of children with asthma experience sleep difficulties due to symptoms like coughing and wheezing. Poor sleep increases the risk of severe asthma exacerbations (attacks) that often necessitate a hospitalization ...

What is myasthenia gravis, the rare disease tennis great Monica Seles lives with?

Former tennis star Monica Seles recently revealed she is living with the rare disease myasthenia gravis, which affects 12 in 100,000 people globally.

Recommended News For You

An FDA panel supports the use of CAR T-cell therapy earlier in the treatment of multiple myeloma.

MCh in Surgical Oncology: Admission, Medical School, Fees, Qualifications Information

AMA President-Elect Confronts a New Challenge: A Brain Tumor

Retifanlimab-Chemo Combo Boosts PFS in Advanced Squamous Cell Anal Cancer

A new blood test greatly increases the ability to detect cancer.

Contradictory Results Are Found in Two Pembrolizumab Trials for Head and Neck Cancer.

The acceptance of innovative hormonal therapy for advanced prostate cancer is racialized.

Recommended Articles For You

Targeted Therapies for Breast Cancer: What’s New? 

The Science Behind Thrombolytic Drugs and Their Benefits  

Essential Oncology Tools: Risk Assessment, Telehealth, AI, and Monitoring 

Unraveling the Mysteries of Coagulopathy: A Comprehensive Definition 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

According to JAMA, even four minutes a day of exercise can lower the risk of cancer.

2.

Preoperative Embolization Linked to Relapse-Free Survival in Meningioma

3.

What Patients Hear From Us: 'Blah, Blah, Tumor, Blah, Blah, Cancer'

4.

Chemotherapy combination boosts overall survival in patients with EGFR-mutant non-small cell lung cancer

5.

Adult overdose deaths on the rise

1.

Holistic Oncology: Advancing Survivorship, Nursing, and Innovative Cancer Care Models

2.

Exploring the Causes and Treatment of Granulocytopenia: A Comprehensive Guide

3.

AI in Genomics: Decoding the Human Genome for Cancer Treatment

4.

Exploring the Hope of New Treatments for Rhabdomyosarcoma

5.

Understanding the Importance of CA125: A Comprehensive Guide 

1.

International Lung Cancer Congress®

2.

Future NRG Oncology Meeting

3.

Genito-Urinary Oncology Summit 2026

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Preventing Blood Clots: The Importance of Venous Thromboembolism Management

2.

Navigating the Complexities of Ph Negative ALL - Part XIV

3.

An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion III

4.

Optimizing Treatment Options in Advanced Urothelial Carcinoma

5.

Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part II

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot